The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 28, 2010
Filed:
Apr. 28, 2008
Mark W. Becker, Redwood City, CA (US);
Harlan H. Chapman, La Honda, CA (US);
Tomas Cihlar, Foster City, CA (US);
Eugene J. Eisenberg, San Carlos, CA (US);
Gong-xin He, Cupertino, CA (US);
Michael R. Kernan, Pacifica, CA (US);
William A. Lee, Los Altos, CA (US);
Ernest J. Prisbe, Los Altos, CA (US);
John C. Rohloff, Boulder, CO (US);
Mark L. Sparacino, Morgan Hill, CA (US);
Mark W. Becker, Redwood City, CA (US);
Harlan H. Chapman, La Honda, CA (US);
Tomas Cihlar, Foster City, CA (US);
Eugene J. Eisenberg, San Carlos, CA (US);
Gong-Xin He, Cupertino, CA (US);
Michael R. Kernan, Pacifica, CA (US);
William A. Lee, Los Altos, CA (US);
Ernest J. Prisbe, Los Altos, CA (US);
John C. Rohloff, Boulder, CO (US);
Mark L. Sparacino, Morgan Hill, CA (US);
Gilead Sciences, Inc., Foster City, CA (US);
Abstract
A novel method has led to the identification of novel mixed ester-amidates of PMPA for retroviral or hepadnaviral therapy, including compounds of structure (5a) having substituent groups as defined herein. Compositions of these novel compounds in pharmaceutically acceptable excipients and their use in therapy and prophylaxis are provided.